Fractals: Life Science Conversations
by The Bracken Group
Latest episode
Operation TrialBlazer: Turning Policy into Progress with Guest Rob…
Operation TrialBlazer: Turning Policy into Progress with Guest Rob…
About this podcast
Insightful, informative, and warmly good-humored, Fractals features life sciences leaders sharing wisdom, career highs and lows, and compelling stories from the intersections of clinical development, health care, and technology. Presented by The Bracken Group.
Episodes
The newest 20 of 40 episodes
- Operation TrialBlazer: Turning Policy into Progress with Guest Rob King · 39 min · Episode 32A roadmap can set the direction. What actually gets a clinical trial moving? In this episode of Fractals: Life Science Conversations, Rob King of Pivotal CRO joins Colin Miller…
- Decoding the Real-World Language of Healthcare with Guest Jo Halliday · 36 min · Episode 31Life sciences doesn’t have a data problem. It has a making-sense-of-the-data problem. In this episode of Fractals: Life Science Conversations, Jo Halliday, CEO and Founder of…
- Beyond the Snapshot: Imaging Biology in Motion with Roughan Sheedy & Beth Fisher · 31 min · Episode 30Imaging has traditionally been used to document what (already) happened. What if it could help determine what happens next? On the newest episode of Fractals, Colin Miller is…
- Beyond Pain Management: A One Medicine Approach to Osteoarthritis with Guests Graham Lumsden and Jonathan Larkin · 34 min · Episode 29What happens when human health, animal health, and entrepreneurial drug development intersect? In this episode of Fractals: Life Science Conversations, Bracken CEO Colin Miller…
- From Simulation to Scale: Rethinking Pharmaceutical Coating with Guest Dr. Michael Choi · 34 min · Episode 28Pharmaceutical manufacturing still struggles with a fundamental challenge: turning complex science into reliable, scalable, real-world processes. Dr. Michael Choi has spent his…
- From Baby Feeding to Better Outcomes: Building Virtual, Preventive Maternal Care with Guest Cory Wyman · 22 min · Episode 27What if maternal care was a proactive partner in your baby’s development, not just stepping in at a point of crisis? On this episode of Fractals, Cory Wyman, Director of…
- Imaging, Trust, and the Real-World: The Current State of Radiopharmaceuticals with Dr. Deepak Behera · 29 min · Episode 26With more than two decades of experience spanning clinical practice, translational research, and global industry leadership, Bracken Senior Partner Dr. Deepak Behera has actively…
- Beyond Baby Steps: Transforming Maternal Health with Guest Mary Hardy · 34 min · Episode 25Mary Hardy, Chief Commercial Officer at SimpliFed, is helping reshape maternal health care with a virtual platform that supports families before birth and well beyond the baby’s…
- Nose to Neurons: The Future of Acute Neuropsychiatric Therapy with Guest Shawn Singh · 36 min · Episode 24What if a nasal spray could switch off acute social anxiety in minutes—without systemic side effects? Shawn Singh, CEO of Vistagen, joins Fractals to explain how pherines work…
- Beyond the Scan: How Radioligands, Ultrasound, and AI Are Redefining Nuclear Medicine with Guest Dr. François Tranquart · 43 min · Episode 23With more than four decades of experience in oncology, cardiovascular imaging, ultrasound, and radioligand therapy, Dr. François Tranquart has helped shape the field of molecular…
- From Big Pharma to Biotech: Lessons in Patient-Centered Drug Development with Dr. David Krause · 5 minWhat does it take to lead successful drug development—whether at a global pharma giant or a small biotech start-up? In this episode of SNiPs, Dr. David Krause joins Bracken CEO…
- Personalized Medicine, Pharma Leadership, and the Human Side of Drug Development with Guest Dr. David Krause · 25 min · Episode 22With more than 30 years of experience spanning global pharma, emerging biotech, and the evolving field of personalized medicine, Bracken Senior Partner Dr. David Krause has…
- Beyond Human Vision: AI’s Role in the Future of Molecular Imaging with Guest Ben Larimer · 8 minCan AI help radiologists see what humans can’t—and speed up drug development in the process? In this episode of SNiPs, Dr. Ben Larimer joins Bracken CEO Dr. Colin Miller to…
- Imaging the Invisible: Granzyme B and the Future of Immunotherapy Monitoring with Guest Dr. Ben Larimer · 35 min · Episode 21As a scientist, innovator, and CEO of CytoSite BioPharma, Dr. Ben Larimer has reshaped how we think about imaging immune response in cancer. His work on Granzyme B PET imaging is…
- Measuring What Matters: Biomarkers, Imaging, and Statistical Rigor with Guest David Raunig · 25 min · Episode 20With more than two decades of experience at the intersection of biostatistics and biomedical imaging, Bracken Senior Partner Dr. David Raunig has been a driving force in…
- Rapid Readouts: How Imaging Biomarkers Accelerate Trials with Guest David Raunig · 6 minIn drug development, the right biomarker can mean the difference between success and a missed opportunity. In this episode of SNiPs, Bracken Senior Partner David Raunig, PhD…
- Biotech Venture Capital: Bubbles, Booms, & Bursts with Guest Lorenzo Pellegrini · 44 min · Episode 19Scientist, entrepreneur, and investor—three small words to describe the way Hatch BioFund Managing Partner Dr. Lorenzo Pellegrini has devoted his career to translating the…
- A Wealth of Experience: Biotech M&A with Guest Lorenzo Pellegrini · 5 minWhat does it take to balance bold innovation with prudent decision-making in biotech? Lorenzo Pellegrini, PhD, Managing Partner at Hatch BioFund, shares his perspective and…
- Reactive to Proactive: Product Development with Guest Graham Lumsden · 37 min · Episode 18With career highlights including the launch of Ivermectin and NuvaRing, along with expertise spanning microbiome therapeutics, M&A, regulatory affairs, and clinical and…
- Practical to Profitable: Product Development with Guest Graham Lumsden · 4 minIn the biopharmaceutical industry, groundbreaking discoveries may start in the lab—but to reach the market, they require more than just great science. In this SNiP, life sciences…
